# Cannabidiol for Fibromyalgia (The CANNFIB Trial)

> **NCT04729179** · PHASE3 · COMPLETED · sponsor: **Marius Henriksen** · enrollment: 200 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04729179
- **Lead sponsor:** Marius Henriksen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2024-02-14
- **Final completion:** 2024-02-14
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04729179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04729179, "Cannabidiol for Fibromyalgia (The CANNFIB Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04729179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*